Shuixiang He
- Molecular Biology top 10%
- Cancer Research top 2%
- Oncology
- Epidemiology
- Surgery
- Co-authors
- Mudan RenYarui LiXinlan LuGuifang LuDan GuoNing ZhangDan ZhangYan Zhao
- Topics
- Cancer-related molecular mechanisms research (20 papers)MicroRNA in disease regulation (19 papers)Circular RNAs in diseases (18 papers)
- Journals
- ACS NanoBiomaterialsOncogene
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Shuixiang He
83 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Molecular Biology 939
- Cancer Research 674
- Oncology 218
- Epidemiology 165
- Surgery 152
Countries citing papers authored by Shuixiang He
This map shows the geographic impact of Shuixiang He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuixiang He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuixiang He more than expected).
Fields of papers citing papers by Shuixiang He
This network shows the impact of papers produced by Shuixiang He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuixiang He. The network helps show where Shuixiang He may publish in the future.
Co-authorship network of co-authors of Shuixiang He
This figure shows the co-authorship network connecting the top 25 collaborators of Shuixiang He. A scholar is included among the top collaborators of Shuixiang He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuixiang He. Shuixiang He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 9 | |
| 7 | An Orally-Administered Nanotherapeutics with Carbon Monoxide Supplying for Inflammatory Bowel Disease Therapy by Scavenging Oxidative Stress and Restoring Gut Immune Homeostasisbreakdown → | 88 |
| 8 | 11 | |
| 9 | 17 | |
| 10 | 41 | |
| 11 | 6 | |
| 12 | 13 | |
| 13 | 4 | |
| 14 | 14 | |
| 15 | [Histone deacetylase 3 inhibitor alleviates alcohol-induced disruption of intestinal epithelial barrier via inhibiting nuclear factor κB]. | 1 |
| 16 | 1 | |
| 17 | 5 | |
| 18 | 109 | |
| 19 | 30 | |
| 20 | 55 |
About Shuixiang He
Shuixiang He is a scholar working on Cancer Research, Toxicology and Gastroenterology, having authored 88 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (20 papers), MicroRNA in disease regulation (19 papers) and Circular RNAs in diseases (18 papers). The work is most often cited by research in Cancer Research (674 citations), Molecular Biology (939 citations) and Toxicology (37 citations). Shuixiang He has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Mudan Ren, Yarui Li, Xinlan Lu, Guifang Lu, Dan Guo, Guifang Lu, Ning Zhang, Dan Zhang, Yan Zhao and Zhenjun Zhao. Their work appears in journals such as ACS Nano, Biomaterials and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.